Literature DB >> 15675953

Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells.

Hideki Fujita1, Akihiko Asahina, Makoto Sugaya, Koichiro Nakamura, Ping Gao, Hiromi Fujiwara, Kunihiko Tamaki.   

Abstract

Some chemokines specifically attract T helper 1 (Th1) cells, whereas others attract T helper 2 (Th2) cells. In this study, we investigated the capacity of Langerhans cells (LC) to produce Th1- and Th2-type chemokines in comparison with that of splenic CD11c(+) dendritic cells (DC). We prepared highly purified (>95%) LC from BALB/c mouse skin using the panning method. With regard to Th1-type chemokines, exogenous stimulus, such as interferon-gamma (IFN-gamma), lipopolysaccharide, or polyinosinic-polycytidylic acid, was mandatory for the production of substantial amounts of CXCL10, CXCL9, and CXCL11 both in LC and splenic DC. LC, as a whole, exhibited low ability to produce Th1-type chemokines in comparison with splenic DC. As for Th2-type chemokines, LC, but not splenic DC, produced high levels of CCL22 and CCL17 constitutively during culture even without exogenous stimuli. The production of Th2-type chemokines was regulated in a complicated manner. In particular, interleukin-4 upregulated, and IFN-gamma downregulated both CCL22 and CCL17 production by LC. Of note, LC produced much more amounts of Th2-type chemokines than splenic DC under any conditions tested. Finally, Th1- and Th2-type chemokines produced by LC were shown to be functional using chemokine receptor-transfected-2B4 T cells. The high production of CC chemokine receptor 4 ligands by LC in the absence of IFN-gamma may be an important character discriminating LC from other DC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15675953     DOI: 10.1111/j.0022-202X.2004.23607.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

Review 1.  Epigenetic regulation of immune cell functions during post-septic immunosuppression.

Authors:  William F Carson; Karen A Cavassani; Yali Dou; Steven L Kunkel
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

2.  Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells.

Authors:  Rebecca J Dearman; Marie Cumberbatch; Gavin Maxwell; David A Basketter; Ian Kimber
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

3.  Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity.

Authors:  Wanhong Ding; Lori L Stohl; John A Wagner; Richard D Granstein
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

4.  Effects of immunomodulatory drugs on TNF-α and IL-12 production by purified epidermal langerhans cells and peritoneal macrophages.

Authors:  Simone R Campelo; Moises B da Silva; José Lf Vieira; Jorge P da Silva; Claudio G Salgado
Journal:  BMC Res Notes       Date:  2011-01-28

5.  Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.

Authors:  Kate Liddiard; John S Welch; Jean Lozach; Sven Heinz; Christopher K Glass; David R Greaves
Journal:  BMC Mol Biol       Date:  2006-11-29       Impact factor: 2.946

Review 6.  Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover.

Authors:  Thorbjørn Krejsgaard; Lise M Lindahl; Nigel P Mongan; Mariusz A Wasik; Ivan V Litvinov; Lars Iversen; Erik Langhoff; Anders Woetmann; Niels Odum
Journal:  Semin Immunopathol       Date:  2016-10-07       Impact factor: 9.623

7.  Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.

Authors:  Blythe D Sather; Piper Treuting; Nikole Perdue; Mike Miazgowicz; Jason D Fontenot; Alexander Y Rudensky; Daniel J Campbell
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

8.  Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis.

Authors:  Masaki Takemura; Takeshi Nakahara; Akiko Hashimoto-Hachiya; Masutaka Furue; Gaku Tsuji
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923

Review 9.  Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.

Authors:  Kazuhiko Matsuo; Sachiko Hirobe; Naoki Okada; Shinsaku Nakagawa
Journal:  Vaccine       Date:  2013-03-21       Impact factor: 3.641

10.  A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection.

Authors:  Yumiko Ishii; Tomoko Nakae; Fumiko Sakamoto; Kazuhiko Matsuo; Keisuke Matsuo; Ying-Shu Quan; Fumio Kamiyama; Takuya Fujita; Akira Yamamoto; Shinsaku Nakagawa; Naoki Okada
Journal:  J Control Release       Date:  2008-07-23       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.